zambia herald : Latest News and In-depth Analysis
HONG KONG,March 18,2025-- In 2024,Roborock,the global leader in ultra-intelligent home robotics engineered to simplify daily life,ranked once again first in global sales volume and turnover amongst R
Deal reflects Liberty Mutual\'s conviction to its focused Asia Pacific strategy BOSTON,March 3,2025-- Liberty Mutual Insurance has agreed to sell its operations in Thailand and Vietnam to Chubb Limit
SHANGHAI,March 17,2025-- Singapore Treasure Carbon TechPte. Ltd. (SGTC) and CHCC Capital (Singapore) Pte. Ltd. have jointly launched a fund that will invest in international carbon credit assets compl
HANGZHOU,China,March 17,2025--Chance Pharmaceuticals ("Chance Pharma"),a clinical-stage biotechnology company dedicated to the research and development of innovative inhalation therapies,to
Six new models announced for AI-enhanced gaming,streaming,and creation with 8K visuals and optimized thermal design with triple FrostBlade 4.0 cooling fans
SHENZHEN,China,March 3,2025-- ISLE 2025,Asia\'s biggest exhibition featuring innovations and solutions in LED display & integrated audio-visual system,will open inShenzhen World Exhibition & C
In the news release,CHARLES LECLERC AND CHIVAS REGAL HIT THE RIGHT NOTE IN NEW GLOBAL PARTNERSHIP,issued 02-Mar-2025 by Chivas Regal over PR Newswire,we are advised by the company that the name of th
5G Automotive Association,JASPAR,Outsight,Safran Passenger Innovations and Seamless Air Alliance embark on journey with GSMA to accelerate new connectivity services
Transformation fromESR Gear to ESR Tech further advances the mission of "Tech Made Easier",enhancing everyday tech experiences with innovative solutions
BARCELONA,Spain,March 4,2025-- Huawei Global Digital Power Summit was held at MWC 2025 with the theme of "AI Powering a Greener ICT." Operators,leading enterprises,industry leaders,and indus
STOBOCLO® (denosumab-bmwo) and OSENVELT® (denosumab-bmwo) are approved by FDA for all indications of reference products PROLIA® (denosumab) and XGEVA® (denosumab) respectively[1],[2]
